1Basile VS, Ozdemir V, Masellis M, et al. A functional polymorphism of the cytochrome P450 1A2 (CYPIA2) gene:association with tardive dyskinesia in schizophrenia. Mol Psychiatry,2000, 5:410-417.
2Schulze TG, Schumacher J, Muller D J, et al. Lack of association between a functional polymorphism of the cytochrome P450 1A2(CYPIA2) gene and tardive dyskinesia in schizophrenia. Am J Med Genet, 2001, 105:498-501.
3Yamada K, Kanba S, Anamizu S, et al. Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia. Psychol Med, 1997, 27:1223-1225.
4Zhang Z, Zhang X, Hou G, et al. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. J Psychiatr Res, 2002, 36:317-324.
5Hori H, Ohmori O, Shinkai T, et al. Managanese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology, 2000.23:170-177.
6Chen CH, Wei FC, Koong FJ, et al. Association of Taq1 A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in ischizophrenia. Biol Psychiatry. 1997.41:827-829.
7Liao DL, Yeh YC, Chen HM, et al. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology,2001,44:95-98.
8Woo SI, Kin JW, Rha E, et al. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics. Psychiatry Clin Neurosci,2002, 56:469-474.
9Steen VM, Lovlie R, MacEwan T, et al. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schisophrenic patients. Mol Psychiatry, 1997, 2:139-145.
10Rietschel M, Krauss H, Muller D J, et al. Dopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci,2000, 250:31-35.
